The Cooper Companies
global medical device company
COO NYSE
ISIN US2166484020 SEC CIK 711404 LEI QJKMVPIGLH7530PCUE20
Follow The Cooper Companies
Weekly email: filings, results
Revenue, last quarter
$1.1B
+0.6% vs same quarter last year
Net income
$432.8M
+340.3% vs same quarter last year
EPS, diluted
$2.24
+357.1% vs same quarter last year
Operating cash flow
$341.7M
+30.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.1B | $374.9M |
| FY24 | $3.9B | $392.3M |
| FY23 | $3.6B | $294.2M |
| FY22 | $3.3B | $385.8M |
| FY21 | $2.9B | $2.9B |
| FY20 | $2.4B | $238.4M |
| FY19 | $2.7B | $466.7M |
| FY18 | $2.5B | $139.9M |
| FY17 | $2.1B | $372.9M |
| FY16 | $2B | $273.9M |
| FY15 | $1.8B | $203.5M |
| FY14 | $1.7B | $269.9M |
| FY13 | $1.6B | $296.2M |
| FY12 | $1.4B | $248.3M |
| FY11 | $1.3B | $175.4M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 65.5% | 16.7% | 9.2% |
| FY24 | 66.6% | 18.1% | 10.1% |
| FY23 | 65.6% | 14.8% | 8.2% |
| FY22 | 64.7% | 15.3% | 11.7% |
| FY21 | 66.9% | 17.3% | 100.8% |
| FY20 | 63.1% | 12.8% | 9.8% |
| FY19 | 66.2% | 20.6% | 17.6% |
| FY18 | 64.4% | 15.9% | 5.5% |
| FY17 | 63.9% | 20.1% | 17.4% |
| FY16 | 59.6% | 16.5% | 13.9% |
| FY15 | 59.6% | 13.2% | 11.3% |
| FY14 | 63.5% | 17.8% | 15.7% |
| FY13 | 64.7% | 19.3% | 18.7% |
| FY12 | 63.9% | 19.6% | 17.2% |
| FY11 | 60.5% | 17.1% | 13.2% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $433.7M |
| FY24 | $288.1M |
| FY23 | $215M |
| FY22 | $450.4M |
| FY21 | $524.2M |
| FY20 | $176.2M |
| FY19 | $421.1M |
| FY18 | $475.3M |
| FY17 | $466.4M |
| FY16 | $357M |
| FY15 | $147.9M |
| FY14 | $216.8M |
| FY13 | $237.8M |
| FY12 | $215.3M |
| FY11 | $232.6M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $0 | $290.1M |
| FY24 | $0 | $0 |
| FY23 | $3M | $0 |
| FY22 | $3M | $78.5M |
| FY21 | $3M | $24.8M |
| FY20 | $3M | $47.8M |
| FY19 | $3M | $156.1M |
| FY18 | $2.9M | $0 |
| FY17 | $2.9M | $55M |
| FY16 | $2.9M | $0 |
| FY15 | $2.9M | $67.3M |
| FY14 | $2.9M | $75.8M |
| FY13 | $2.9M | $167.3M |
| FY12 | $2.9M | $71.2M |
| FY11 | $2.8M | $0 |
- The Cooper Companies
- Healthcare median
Show the numbers
| Year | The Cooper Companies | Healthcare median |
|---|---|---|
| FY25 | 9.2% | −30.6% |
| FY24 | 10.1% | −47% |
| FY23 | 8.2% | −58% |
| FY22 | 11.7% | −80.4% |
| FY21 | 100.8% | −71.9% |
| FY20 | 9.8% | −62.2% |
| FY19 | 17.6% | −46.3% |
| FY18 | 5.5% | −49.6% |
| FY17 | 17.4% | −45.9% |
| FY16 | 13.9% | −36% |
| FY15 | 11.3% | −38.4% |
| FY14 | 15.7% | −35.5% |
| FY13 | 18.7% | −37.1% |
| FY12 | 17.2% | −29.1% |
| FY11 | 13.2% | −27.9% |